Estimating renin participation in hypertension: Superiority of converting enzyme inhibitor over saralasin
- 30 November 1976
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 61 (5) , 790-796
- https://doi.org/10.1016/0002-9343(76)90160-1
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A Role for Renin in Rebound Hypertension and Encephalopathy after Infusion of Saralasin Acetate (Sar1-Ala8-Angiotensin II)New England Journal of Medicine, 1976
- Usefulness and limitations of saralasin, a partial competitive agonist of angiotensin II, for evaluating the renin and sodium factors in hypertensive patientsThe American Journal of Medicine, 1976
- The role of the renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal human subjects.Circulation, 1976
- Renin Release, Saralasin and the Vasodilator-Beta-Blocker Drug Interaction in ManNew England Journal of Medicine, 1975
- Use of an Angiotensin II Antagonist (Saralasin) in the Recognition of “Angiotensinogenic” HypertensionNew England Journal of Medicine, 1975
- Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes.Circulation Research, 1975
- Vasoconstriction-volume analysis for understanding and treating hypertension: The use of renin and aldosterone profilesThe American Journal of Medicine, 1973
- Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular diseaseThe American Journal of Medicine, 1972
- Role of the Pressor Action of Angiotensin IIin Experimental HypertensionCirculation Research, 1971
- THE LIBERATION OF RENIN BY PERFUSION OF KIDNEYS FOLLOWING REDUCTION OF PULSE PRESSUREThe Journal of Experimental Medicine, 1940